Skip to main content

J1746 HCPCS Level II Code: Injection, ibalizumab-uiyk, 10 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj., ibalizumab-uiyk, 10 mg
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2019

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Change history

  • January 1, 2019
    Added to the code set
    Injection, ibalizumab-uiyk, 10 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $79.51

62064-0122-02 — Trogarzo — Theratechnologies Inc. (size 1.33 × qty 2 (10 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1746 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (23)

Change history

  • January 1, 2019 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1746 in its code family, with their registry titles.